Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026)
Scilex Holding (SCLX) posted Other Operating Expenses of -$9.3 million for Q2 2026, up 48.75% on a QoQ basis from -$18.1 million in Q1 2026.
Analysis
Scilex Holding (SCLX) Other Operating Expenses (2020 - 2026) Analysis & Trends
Scilex Holding has reported Other Operating Expenses for 7 years, with the latest figure at -$9.3 million in Q2 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$9.3 million in Q2 2026; TTM through Jun 2026 was -$39.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$12.2 million, changed N/A from the prior year.
- Other Operating Expenses was -$9.3 million for Q2 2026 at Scilex Holding, up from -$18.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $5.5 million in Q4 2023, with the low at -$18.1 million in Q1 2026.
- Average Other Operating Expenses over 5 years is -$555227.6, with a median of $3.7 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses surged 4961.73% in 2022, then slumped 143.83% in 2024.
- Over 5 years, Other Operating Expenses stood at $5.5 million in 2022, then increased by 0.14% to $5.5 million in 2023, then decreased by 2.81% to $5.4 million in 2024, then sank by 413.15% to -$16.9 million in 2025, then soared by 45.16% to -$9.3 million in 2026.
- The last three Other Operating Expenses figures came in at -$9.3 million (Q2 2026), -$18.1 million (Q1 2026), and -$16.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 446.62 Bn | 440.05 Bn | 12.70 Bn |
| 3 | Merck | 358.24 Bn | 351.10 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.40 Bn | 260.71 Bn | 11.24 Bn |
| 5 | Pfizer | 157.04 Bn | 145.34 Bn | 10.94 Bn |
| 6 | Sanofi | 52.18 Bn | 44.80 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - |
| 8 | Incyte | 24.83 Bn | 20.30 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.38 Bn | 18.72 Bn | 683.80 Mn |
| 10 | Scilex Holding | 35.87 Mn | -76.92 Mn | 3.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.26 Mn |
| Mar 31, 2026 | -18.06 Mn |
| Dec 31, 2025 | -16.88 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2024 | 5.39 Mn |
| Mar 31, 2024 | -2.02 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.62 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 526,359.00 |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | -485,807.00 |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | -1.16 Mn |
| Jun 30, 2021 | -61,609.00 |
| Mar 31, 2021 | 1.49 Mn |
| Dec 31, 2020 | 6,276.00 |
| Sep 30, 2020 | 5,856.00 |